Targeting Pim2 Improves Antitumor Immunity through Promoting Effector Function and Persistence of CD8 T cells

Journal:

Journal of Clinical Investigation

Published:

2026-01-27

DOI:

10.1172/jci192928

Affiliations:

7

Authors:

12

Go to article

Institutions	Authors	Share
Medical College of Wisconsin (MCW), United States of America (USA)	6.000000	0.50
Medical University of South Carolina (MUSC), United States of America (USA)	2.000000	0.17
Northwestern University (NU), United States of America (USA)	1.000000	0.08
Loyola University Chicago (LUC), United States of America (USA)	1.000000	0.08
MCW Cancer Center, United States of America (USA)	1.000000	0.08
University of Colorado Cancer Center, United States of America (USA)	1.000000	0.08

Interested in Oncology and Carcinogenesis?